Current Treatment and Immunomodulation Strategies in Acute Myocarditis

Emma Ferone, Amitai Segev, Erika Tempo, Piero Gentile, Ahmed Elsanhoury, Chiara Baggio, Jessica Artico, Prashan Bhatti, Paul Scott, Emanuele Bobbio, Marco Merlo, Pietro Ameri, Gianfranco Sinagra, Carsten Tschöpe, Daniel Bromage*, Antonio Cannata

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

1 Citation (Scopus)

Abstract

Myocarditis is an inflammatory disease of the myocardium characterized by a great heterogeneity of presentation and evolution. Treatment of myocarditis is often supportive, and the evidence for immunosuppression is scarce and debated. Conventional treatment is based on clinical presentation, ranging from conservative to advanced mechanical assist devices. In this setting, immunosuppression and immunomodulation therapies are mostly reserved for patients presenting with major clinical syndromes. In this review, we will summarize the current evidence and strategies for conventional and immunosuppressive treatments for patients presenting with acute myocarditis.

Original languageEnglish
Pages (from-to)364-376
Number of pages13
JournalJournal of Cardiovascular Pharmacology
Volume83
Issue number5
DOIs
Publication statusPublished - 2 May 2024

Keywords

  • immunosuppression
  • inflammation
  • inflammatory disease
  • myocarditis
  • steroids
  • treatment

Fingerprint

Dive into the research topics of 'Current Treatment and Immunomodulation Strategies in Acute Myocarditis'. Together they form a unique fingerprint.

Cite this